Guo X, Li S
Oncol Rep. 2025; 53(4).
PMID: 39981932
PMC: 11865881.
DOI: 10.3892/or.2025.8879.
Sirek T, Krol-Jatrega K, Borawski P, Zmarzly N, Boron D, Ossowski P
Front Oncol. 2025; 14():1515387.
PMID: 39850811
PMC: 11754234.
DOI: 10.3389/fonc.2024.1515387.
Li Y, Tang X, Wang B, Chen M, Zheng J, Chang K
Noncoding RNA Res. 2024; 9(4):1351-1362.
PMID: 39247145
PMC: 11380467.
DOI: 10.1016/j.ncrna.2024.07.003.
Casara A, Conti M, Bernardinello N, Tine M, Baraldo S, Turato G
Int J Mol Sci. 2024; 25(13).
PMID: 39000595
PMC: 11242851.
DOI: 10.3390/ijms25137490.
Rizwan M, Mahjabeen I, Ashraf N, Arshad M, Haris M, Kayani M
Future Oncol. 2024; 20(21):1479-1493.
PMID: 38861304
PMC: 11441060.
DOI: 10.1080/14796694.2024.2351355.
The regulatory process and practical significance of non-coding RNA in the dissemination of prostate cancer to the skeletal system.
Sang H, Li L, Zhao Q, Liu Y, Hu J, Niu P
Front Oncol. 2024; 14:1358422.
PMID: 38577343
PMC: 10991771.
DOI: 10.3389/fonc.2024.1358422.
Integrative Metabolomic Analysis of Serum and Selected Serum Exosomal microRNA in Metastatic Castration-Resistant Prostate Cancer.
Evin D, Evinova A, Baranovicova E, Sarlinova M, Jurecekova J, Kaplan P
Int J Mol Sci. 2024; 25(5).
PMID: 38473877
PMC: 10932184.
DOI: 10.3390/ijms25052630.
Emerging role of transforming growth factor-β-regulated long non-coding RNAs in prostate cancer pathogenesis.
Shree B, Das K, Sharma V
Cancer Pathog Ther. 2024; 1(3):195-204.
PMID: 38327834
PMC: 10846338.
DOI: 10.1016/j.cpt.2022.12.003.
The miR-19a/Cylindromatosis Axis Regulates Pituitary Adenoma Bone Invasion by Promoting Osteoclast Differentiation.
Lei Z, Wang Q, Jiang Q, Liu H, Xu L, Kang H
Cancers (Basel). 2024; 16(2).
PMID: 38254792
PMC: 10813535.
DOI: 10.3390/cancers16020302.
Decoding the interaction between miR-19a and CBX7 focusing on the implications for tumor suppression in cancer therapy.
Zabeti Touchaei A, Vahidi S, Samadani A
Med Oncol. 2023; 41(1):21.
PMID: 38112798
DOI: 10.1007/s12032-023-02251-y.
H19 encourages aerobic glycolysis and cell growth in gastric cancer cells through the axis of microRNA-19a-3p and phosphoglycerate kinase 1.
Chen S, Wang H, Xu P, Dang S, Tang Y
Sci Rep. 2023; 13(1):17181.
PMID: 37821504
PMC: 10567772.
DOI: 10.1038/s41598-023-43744-0.
The Bone Microenvironment Soil in Prostate Cancer Metastasis: An miRNA Approach.
Prigol A, Rode M, da Luz Efe F, Saleh N, Creczynski-Pasa T
Cancers (Basel). 2023; 15(16).
PMID: 37627055
PMC: 10452124.
DOI: 10.3390/cancers15164027.
[Diagnostic and prognostic value of serum miR-19a-3p in patients with multiple myeloma].
Wei X, Liu L, Sun H, Qiu L, Hao M
Zhonghua Xue Ye Xue Za Zhi. 2023; 43(7):598-601.
PMID: 36709139
PMC: 9395561.
DOI: 10.3760/cma.j.issn.0253-2727.2022.07.012.
Formation of pre-metastatic bone niche in prostate cancer and regulation of traditional chinese medicine.
Chen C, Huang R, Zhou J, Guo L, Xiang S
Front Pharmacol. 2022; 13:897942.
PMID: 36059977
PMC: 9428453.
DOI: 10.3389/fphar.2022.897942.
Downregulation of decreases survival gene expression, promotes apoptosis and affects the cell cycle of gastric cancer cells.
Rossi A, da Silva Manoel-Caetano F, Biselli J, Cabral A, Saiki M, Ribeiro M
World J Gastroenterol. 2022; 28(24):2689-2704.
PMID: 35979166
PMC: 9260869.
DOI: 10.3748/wjg.v28.i24.2689.
LINC00094/miR-19a-3p/CYP19A1 axis affects the sensitivity of ER positive breast cancer cells to Letrozole through EMT pathway.
Xiang Y, Liu H, Hu H, Li L, Zong Q, Wu T
Aging (Albany NY). 2022; 14(11):4755-4768.
PMID: 35657638
PMC: 9217696.
DOI: 10.18632/aging.204110.
Noncoding RNA actions through IGFs and IGF binding proteins in cancer.
Kerr A, Baxter R
Oncogene. 2022; 41(25):3385-3393.
PMID: 35597813
PMC: 9203274.
DOI: 10.1038/s41388-022-02353-3.
MicroRNA-19a-3p Acts as an Oncogene in Gastric Cancer and Exerts the Effect by Targeting SMOC2.
Xu H, Lu G, Zhou S, Fang F
Appl Biochem Biotechnol. 2022; 194(9):3833-3842.
PMID: 35543855
DOI: 10.1007/s12010-022-03944-2.
miR-500a-3p is a Potential Prognostic Biomarker in Hepatocellular Carcinoma.
Long J, Liu B, Yao Z, Weng H, Li H, Jiang C
Int J Gen Med. 2022; 15:1891-1899.
PMID: 35221718
PMC: 8881010.
DOI: 10.2147/IJGM.S340629.
The Emerging Role of MicroRNAs in Bone Diseases and Their Therapeutic Potential.
Bravo Vazquez L, Moreno Becerril M, Mora Hernandez E, Leon Carmona G, Aguirre Padilla M, Chakraborty S
Molecules. 2022; 27(1).
PMID: 35011442
PMC: 8746945.
DOI: 10.3390/molecules27010211.